Global Lung Cancer Surgery Market Overview:
Global Lung Cancer Surgery Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Lung Cancer Surgery Market Report 2026 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Lung Cancer Surgery involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Lung Cancer Surgery Market:
The Lung Cancer Surgery Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Lung Cancer Surgery Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Lung Cancer Surgery Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Lung Cancer Surgery market has been segmented into:
Thoracotomy
Minimally Invasive Surgery
By Application, Lung Cancer Surgery market has been segmented into:
Surgical Instruments
Monitoring & Visualizing Systems
Endosurgical Equipment).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Lung Cancer Surgery market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Lung Cancer Surgery market.
Top Key Players Covered in Lung Cancer Surgery market are:
Abbott Molecular Inc.
AbbVie Inc.
Accuray Inc.
Ackermann Instrumente GmbH
AngioDynamics Inc.
Baxter International Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Daiichi Sankyo Co. Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Lung Cancer Surgery Market Type
4.1 Lung Cancer Surgery Market Snapshot and Growth Engine
4.2 Lung Cancer Surgery Market Overview
4.3 Thoracotomy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Thoracotomy: Geographic Segmentation Analysis
4.4 Minimally Invasive Surgery
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Minimally Invasive Surgery: Geographic Segmentation Analysis
Chapter 5: Lung Cancer Surgery Market Application
5.1 Lung Cancer Surgery Market Snapshot and Growth Engine
5.2 Lung Cancer Surgery Market Overview
5.3 Surgical Instruments
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Surgical Instruments: Geographic Segmentation Analysis
5.4 Monitoring & Visualizing Systems
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Monitoring & Visualizing Systems: Geographic Segmentation Analysis
5.5 Endosurgical Equipment).
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Endosurgical Equipment).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Lung Cancer Surgery Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT MOLECULAR
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; ABBVIE
6.4 INC.; ACCURAY
6.5 INC.; ACKERMANN INSTRUMENTE GMBH; ANGIODYNAMICS
6.6 INC.; BAXTER INTERNATIONAL
6.7 INC.; BOEHRINGER INGELHEIM INTERNATIONAL GMBH; BRISTOL-MYERS SQUIBB COMPANY; CELGENE CORPORATION; DAIICHI SANKYO CO.
6.8 LTD.
Chapter 7: Global Lung Cancer Surgery Market By Region
7.1 Overview
7.2. North America Lung Cancer Surgery Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Thoracotomy
7.2.2.2 Minimally Invasive Surgery
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Surgical Instruments
7.2.3.2 Monitoring & Visualizing Systems
7.2.3.3 Endosurgical Equipment).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Lung Cancer Surgery Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Thoracotomy
7.3.2.2 Minimally Invasive Surgery
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Surgical Instruments
7.3.3.2 Monitoring & Visualizing Systems
7.3.3.3 Endosurgical Equipment).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Lung Cancer Surgery Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Thoracotomy
7.4.2.2 Minimally Invasive Surgery
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Surgical Instruments
7.4.3.2 Monitoring & Visualizing Systems
7.4.3.3 Endosurgical Equipment).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Lung Cancer Surgery Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Thoracotomy
7.5.2.2 Minimally Invasive Surgery
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Surgical Instruments
7.5.3.2 Monitoring & Visualizing Systems
7.5.3.3 Endosurgical Equipment).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Lung Cancer Surgery Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Thoracotomy
7.6.2.2 Minimally Invasive Surgery
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Surgical Instruments
7.6.3.2 Monitoring & Visualizing Systems
7.6.3.3 Endosurgical Equipment).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Lung Cancer Surgery Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Thoracotomy
7.7.2.2 Minimally Invasive Surgery
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Surgical Instruments
7.7.3.2 Monitoring & Visualizing Systems
7.7.3.3 Endosurgical Equipment).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Lung Cancer Surgery Scope:
|
Report Data
|
Lung Cancer Surgery Market
|
|
Lung Cancer Surgery Market Size in 2025
|
USD XX million
|
|
Lung Cancer Surgery CAGR 2025 - 2032
|
XX%
|
|
Lung Cancer Surgery Base Year
|
2024
|
|
Lung Cancer Surgery Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Molecular Inc., AbbVie Inc., Accuray Inc., Ackermann Instrumente GmbH, AngioDynamics Inc., Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Celgene Corporation, Daiichi Sankyo Co. Ltd..
|
|
Key Segments
|
By Type
Thoracotomy
Minimally Invasive Surgery
By Applications
Surgical Instruments
Monitoring & Visualizing Systems
Endosurgical Equipment).
|
